Pepric

Foundation date

14/04/2009

Sector

#Supplier & Engineering

Subsector

Therapeutic areas

Pepric provides pEPR (particle Electron Paramagnetic Resonance) instruments for in-vitro quantification of superparamagnetic nanoparticles in samples. Fast and accurate measurements by Pepric's robotized particle spectrometer are used for the preclinical tests of hyperthermia or (stem) cell therapies in oncology, cardiology, dermatology, and etc, and in vaccine developments by tracking the pharmacokinetics of therapeutic particles, (stem) cells, medicines or vaccine carriers that utilize super paramagnetic iron oxide nano particles (SPION) or magnetic nano particles (MNP).

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    8 hours ago

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022